Search Results - "Depuydt, Lieselotte"

Outcome and toxicity of hypofractionated image-guided SABR for spinal oligometastases by Billiet, Charlotte, Joye, Ines, Mercier, Carole, Depuydt, Lieselotte, De Kerf, Geert, Vermeulen, Peter, Van Laere, Steven, Van de Kelft, Erik, Meijnders, Paul, Verellen, Dirk, Dirix, Piet

“…•Hypofractionated stereotactic ablative radiotherapy (SABR) in patients with spinal oligometastases.•High rates of efficacy and minimal…”
Get full text

Stereotactic body and conformal radiation therapy in primary and secondary liver malignancies: Local in-field control by Latacz, Emily, van Dam, Pieter-Jan, Meersman, Pieter, Dirix, Piet, Meijnders, Paul, Depuydt, Lieselotte, Van Laere, Steven, Dirix, Luc, Weytjens, Reinhilde

Get full text

The TRENDY multi-center randomized trial on hepatocellular carcinoma – Trial QA including automated treatment planning and benchmark-case results by Habraken, Steven J.M., Sharfo, Abdul Wahab M., Buijsen, Jeroen, Verbakel, Wilko F.A.R., Haasbeek, Cornelis J.A., Öllers, Michel C., Westerveld, Henrike, van Wieringen, Niek, Reerink, Onne, Seravalli, Enrica, Braam, Pètra M., Wendling, Markus, Lacornerie, Thomas, Mirabel, Xavier, Weytjens, Reinhilde, Depuydt, Lieselotte, Tanadini-Lang, Stephanie, Riesterer, Oliver, Haustermans, Karin, Depuydt, Tom, Dwarkasing, Roy S., Willemssen, François E.J.A., Heijmen, Ben J.M., Méndez Romero, Alejandra

“…The TRENDY trial is an international multi-center phase-II study, randomizing hepatocellular carcinoma (HCC) patients between transarterial chemoembolization…”
Get full text